Invasive group A streptococcus in a skilled nursing facility--Pennsylvania, 2009-2010.

In September 2010, the Pennsylvania Department of Health was notified of a cluster of invasive group A Streptococcus (GAS) infections among residents of a skilled nursing facility specializing in neurologic and pulmonary care. The Montgomery County Health Department, the Pennsylvania Department of Health, and CDC conducted an investigation to identify additional cases and GAS carriers, assess risk factors and infection prevention practices, implement control measures, and prevent further infections. The investigators determined that, during October 12, 2009-September 22, 2010, 10 residents at the facility had noninvasive GAS infection, and 13 had invasive GAS infection; two residents with invasive infection died. An additional seven culture-confirmed GAS infections could not be characterized as cases because the residents' symptoms were unknown. Staff members and residents were screened by culture to identify GAS carriers, who were then administered antibiotics. Multiple infection prevention deficiencies were noted at the facility, including ineffective hand hygiene practices among staff members. Education on infection prevention practices was provided, and active surveillance was implemented. Invasive GAS outbreaks in long-term-care facilities often result in high death rates. Long-term-care facilities, including skilled nursing facilities, should investigate single cases of invasive GAS infection and ensure that infection prevention measures are fully implemented.

[1]  Alex Harocopos,et al.  Initiation into prescription opioid misuse amongst young injection drug users. , 2012, The International journal on drug policy.

[2]  P. Leggat Tropical Infectious Diseases: Principles, Pathogens and Practice , 2011 .

[3]  Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. , 2010, MMWR. Morbidity and mortality weekly report.

[4]  Leonard A. Smith,et al.  Botulinum Neurotoxin Vaccines: Past history and recent developments , 2009, Human vaccines.

[5]  N. Dasgupta,et al.  Illicit use of opioids: is OxyContin a "gateway drug"? , 2007, The American journal on addictions.

[6]  Leonard A. Smith,et al.  Botulinum neurotoxin vaccines: past, present, and future. , 2007, Critical reviews in immunology.

[7]  E. Ruiz-Tiben,et al.  Dracunculiasis (Guinea worm disease) eradication. , 2006, Advances in parasitology.

[8]  S. Weber,et al.  Rotavirus infection in adults , 2004, The Lancet Infectious Diseases.

[9]  M. E. Levy,et al.  Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus. , 2002, The Journal of infectious diseases.

[10]  J. Evans,et al.  Report of a rotavirus outbreak in an adult nursing home population. , 2000, Journal of the American Medical Directors Association.

[11]  H. Margolis,et al.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .

[12]  G. Rao Control of outbreaks of viral diarrhoea in hospitals--a practical approach. , 1995, The Journal of hospital infection.

[13]  E. Ruiz-Tiben,et al.  Permanent disability from dracunculiasis , 1990, The Lancet.

[14]  S. Watts Dracunculiasis in Africa in 1986: its geographic extent, incidence, and at-risk population. , 1987, The American journal of tropical medicine and hygiene.

[15]  S. Sattar,et al.  Chemical disinfection of human rotaviruses: efficacy of commercially-available products in suspension tests , 1986, Journal of Hygiene.

[16]  W. Emmett Barkley,et al.  Biosafety in microbiological and biomedical laboratories , 1984 .